← Leaderboards
Sandra M Gaston
Beth Israel Deaconess Medical Center
$1,852,296
Attributed
$3,733,094
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $864.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,733,094 · 5
By mechanism
R01$1,497,955 · 1
U01$1,323,242 · 1
R21$911,897 · 3
Top collaborators
- Alan Pollack7 shared
- Radka Stoyanova4 shared
- Sanoj Punnen3 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Christian Dibble$2,499,030
- Martin R. Pollak$37,233,145
- Vassiliki A Boussiotis$19,288,605
- Mark A Herman$6,685,137
- Keisuke Ito$9,818,052
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTissuesMagnetic Resonance ImagingMalignant Neoplasm Of ProstateProstateClinical TrialsGenesProtocols DocumentationPositioning AttributeMolecularProstate BiopsyEarly Detection Research NetworkPatternCharacteristicsProstate Cancer RiskStandard Of CareBiopsy SpecimenRisk AssessmentSamplingBiopsyDetectionGene ExpressionReproducibilityStandardization
Grant awards (13)
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection$499,867
R01 · FY2025 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$351,131
U01 · FY2025 · CA
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection$477,798
R01 · FY2024 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$276,871
U01 · FY2024 · CA
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection$520,290
R01 · FY2023 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$344,109
U01 · FY2023 · CA
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness$351,131
U01 · FY2022 · CA
Choline Metabolism in Prostate Cancers: Response to Dietary Soy Phytochemicals$170,000
R21 · FY2008 · CA · contact PI
Choline Metabolism in Prostate Cancers: Response to Dietary Soy Phytochemicals$198,280
R21 · FY2007 · CA · contact PI
Prostate MRI and MRS: Correlations with Gene Expression$125,453
R21 · FY2007 · CA · contact PI
Tissue Print Micropeels for Molecular Profiling Cancer$142,764
R21 · FY2006 · CA · contact PI
Prostate MRI and MRS: Correlations with Gene Expression$129,200
R21 · FY2006 · CA · contact PI
Tissue Print Micropeels for Molecular Profiling Cancer$146,200
R21 · FY2005 · CA